Primary tabs
The list of publications is indicative and may not include all publications.
Laboratory investigation of platelet function in patients with thalassaemia..
Acta Haematol. 132(1), 45-8.
(2014).
Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy..
Mol Biol Rep. 39(5), 6101-5.
(2012).
Safety of deferasirox in sickle cell disease patients with co-existing liver impairment..
Br J Haematol. 157(4), 505-6; author reply 506-7.
(2012).
Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major..
Pediatr Pulmonol. 47(8), 801-7.
(2012).
Pure red cell aplasia and lymphoproliferative disorders: an infrequent association..
ScientificWorldJournal. 2012, 475313.
(2012).
Is deferasirox implicated in multiple organ failure in a patient with homozygous β-thalassemia?.
Angiology. 62(4), 346-8.
(2011).
Haematoma caused by bone marrow aspiration and trephine biopsy..
Hematol Rep. 3(3), e25.
(2011).
Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major..
Eur J Haematol. 84(1), 64-71.
(2010).
Is liver stiffness really unrelated to liver iron concentration?.
Br J Haematol. 150(2), 247-8.
(2010).
High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes..
Acta Haematol. 124(3), 141-9.
(2010).
Fatal chylous ascites, pericarditis and extensive venous thrombosis, due to an aggressive T cell non-Hodgkin lymphoma..
Ann Hematol. 88(4), 371-3.
(2009).
MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations..
Eur J Haematol. 82(5), 388-92.
(2009).
Parotid gland oncocytoma: a case report..
Cases J. 2, 6423.
(2009).